Identification of chlamydospore-negative Candida albicans using CHROMagar Candida medium

Mycoses

Volumn 46, Issue 3-4, 2003, Pages 96-103

  Fotedar, Rashmi ^a,b   Al Hedaithy, S S A ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b c/o Mr Rajeev Kaul ^*  (Saudi Arabia)

Author keywords

Candida albicans; Chlamydospore negative; CHROMagar

Indexed keywords

ASPARTIC ACID; CHROMOGENIC SUBSTRATE; GLUCOSAMINE; N ACETYLGLUCOSAMINE; PROTEINASE; TREHALOSE;

ARTICLE; CANDIDA ALBICANS; COLOR; CULTURE MEDIUM; ENZYME SYNTHESIS; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPING; STRAIN DIFFERENCE; TEMPERATURE DEPENDENCE;

ADULT; AGAR; CANDIDA ALBICANS; CANDIDIASIS; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; FEMALE; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; SPORES, FUNGAL;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0038076174     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00867.x     Document Type: Article

References (21)

1. Pfaller MA. Epidemiology of fungal infections. J Hosp Infect 1995; 30 (Suppl.): 329-38.
2. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-25.
3. Ghannoum MA. Is antifungal susceptibility testing useful in guiding fluconazole therapy? Clin Infect Dis 1996: 22 (Suppl.): S161-5.
4. Rex JH. Pfaller MA. Barry AL. Nelson PW. Webb CD. Antifungal susceptibility testing of isolates from a randomized. multicenter trial of fluconazole versus amphotericin B as treatment of non neutropenic patients with candidemia. Antimicrob Agents Chemother 1995: 39: 40-44.
5. Odds FC. Bernaerts R. CHROMagar Candida. a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923-9.
6. Al-Hedaithy SSA. The medically important yeasts present in clinical specimens. Ann Saudi Med 1992: 12: 57-62.
7. Rinaldi MG. Biology and pathogenicity of Candida species, In: Bodey GP (ed.). Candidiasis: pathogenesis, diagnosis and treatment. 2nd edn. New York: Raven Press. 1993: 1-20.
8. Warren NG. Hazen KC. Candida, Cryptococcus and other yeasts of medical importance. In Balows A. Hausler WJ Jr. Hermann KL. Isenberg HD. Shadomy HJ (eds). Manual of Clinical Microbiology, 5th edn. American Society for Microbiology, Washington, D.C., 1995: 723-37.
9. Davey KG. Chant PM. Downer CS. Campbell CK. Warnock DW. Evaluation of the Auxacolor System, a new method of clinical yeast identification. J Clin Pathol 1995: 48: 807-9.
10. Crow SA. Bowman PI. Ahearn DG. Isolation of atypical Candida albicans from the North Sea. Appl Environ Microbiol 1997: 33: 738-9.
11. Wickes BL. Hicks JB. Merz WG. Kwon-chung KJ. The molecular analysis of synonymy among medically important yeasts within the genus Candida. J Gen Microbiol 1992; 138: 901-7.
12. Mahrous M. Lott TJ. Meyer SA. Sawant AD. Ahearn DG. Electrophoretic karyotyping of typical and atypical Candida albicans. J Clin Microbiol 1990: 28: 876-81.
13. Tietz HJ. Kussner A, Thanos M. De Andrade PD. Presber W. Schonian G. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J Clin Microbiol 1995: 33: 2462-5.
14. Steffan P. Vazquez JA. Boikov D. Xu C. Sobel JD, Akins RA. Identification of Candida species by randomly amplified polymorphic DNA finger printing of colony lysates. J Clin Microbiol 1997: 35: 2031-9.
15. Baumgartner C. Freydiere AM. Gille Y. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol 1996: 34: 454-6.
16. Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999; 42: 61-65.
17. Al-Hedaithy SSA. Fotedar R. Recovery and studies on chlamydospore-negative Candida albicans isolated from clinical specimens. Medical Mycology 2002: 40: 301-3.
18. Cassone A. De Bernardis F. Mondello F. Ceddia T. Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidiosis. J Infect Dis 1987; 156: 777-83.
19. Odds FC. Nuffel LV, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998: 36: 2869-73.
20. Perry JL, Matthews JS. Sheets TJ. Comparison of rapid kit and selective chromogenic media for the presumptive identification of Canddda albicans and other yeasts. 35th ICAAC meeting, December 1995. San Francisco, CA
21. Quindos G, SanMillan R, Robert R, Bernard C. Ponton J. Evaluation of Bichro-latex Albicans, a new method for rapid identification of Candida albicans. J Clin Microbiol 1997: 35: 1263-5.